PRA number
2019/17313
Published date
Product description
OA/RA capsules
Batch No: 17098003
OA/RA is an Ayurvedic product that is indicated for temporary pain relief of osteoarthritis (OA) and rheumatoid arthritis (RA).
Batch No: 17098003
OA/RA is an Ayurvedic product that is indicated for temporary pain relief of osteoarthritis (OA) and rheumatoid arthritis (RA).
Reasons the product is recalled
A single batch (Batch 17098003) of OA/RA Capsules are being recalled due to contamination with a substance that poses an unacceptable risk to health. This product has also been withdrawn from the Australian market and will no longer be available for supply.
TGA testing has found that the currently available batch of the product is contaminated with very low levels of aristolochic acid.
TGA testing has found that the currently available batch of the product is contaminated with very low levels of aristolochic acid.
The hazards to consumers
Aristolochic acid is included in Schedule 10 to the Poisons Standard, which lists substances considered to pose an unacceptable risk to health. There is no established safe exposure level to aristolochic acids, which have been linked to kidney problems and urinary tract cancers.
What consumers should do
If you or someone you provide care for takes OA/RA capsules, please be alert to this issue and discontinue use immediately. The product should not be consumed.
If you have any OA/RA capsules, the remaining product can be returned to the place of purchase for a refund.
If you have any questions or concerns about this issue, talk to your health professional or contact 1300 133 807.
If you have any OA/RA capsules, the remaining product can be returned to the place of purchase for a refund.
If you have any questions or concerns about this issue, talk to your health professional or contact 1300 133 807.
Supplier
BlueSkyGreenEarth Herbs Pty Ltd
Traders who sold this product
Various herbalists, practitioners and health stores
Where the product was sold
Australian Capital Territory
New South Wales
Queensland
South Australia
Tasmania
Victoria
Western Australia
Responsible regulator
Therapeutic Goods Administration is the responsible regulator for this recall.